Rapamycin inhibits IGF-1-mediated up-regulation of MDM2 and sensitizes cancer cells to chemotherapy
about
ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies.Differential expression of microRNA501-5p affects the aggressiveness of clear cell renal carcinoma.High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia.
P2860
Rapamycin inhibits IGF-1-mediated up-regulation of MDM2 and sensitizes cancer cells to chemotherapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Rapamycin inhibits IGF-1-media ...... s cancer cells to chemotherapy
@ast
Rapamycin inhibits IGF-1-media ...... s cancer cells to chemotherapy
@en
type
label
Rapamycin inhibits IGF-1-media ...... s cancer cells to chemotherapy
@ast
Rapamycin inhibits IGF-1-media ...... s cancer cells to chemotherapy
@en
prefLabel
Rapamycin inhibits IGF-1-media ...... s cancer cells to chemotherapy
@ast
Rapamycin inhibits IGF-1-media ...... s cancer cells to chemotherapy
@en
P2093
P2860
P1433
P1476
Rapamycin inhibits IGF-1-media ...... s cancer cells to chemotherapy
@en
P2093
Haibo Zhang
Haoqiang Ying
Johann Bergholz
Junfeng Wu
Yujun Zhang
Zhi-Xiong Jim Xiao
P2860
P304
P356
10.1371/JOURNAL.PONE.0063179
P407
P577
2013-04-30T00:00:00Z